Company: BBVXF
Filing Date: 2025-08-12
Form Type: DRS
Source: 0000950123-25-007520
Chunk: 253

Company: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Filing Date: 2025-08-12
Form: DRS
Chunk 253
---
 BBVA’s share capital as of the
date of the authorization (equivalent to 666,788,658 new BBVA shares). The board of directors’ authorization to issue securities convertible into newly-issued BBVA shares other than CoCos expires on March 18, 2027. As of the date of this
offer to exchange/prospectus, BBVA’s board of directors has not exercised this authorization.

169

As confidentially submitted to the Securities and Exchange Commission on August 11, 2025.

This Amendment No. 4 has not been publicly filed with the Securities and Exchange Commission and all

information herein remains strictly confidential.

At the ordinary general shareholders’ meeting of BBVA held on March 18, 2022,
BBVA’s shareholders also approved, among other resolutions, an authorization for BBVA, either directly or through its subsidiaries, to acquire its own shares for a maximum period of five years from the date of approval of the resolution (which
replaces the authorization granted at the general shareholders’ meeting held on March 16, 2018), at any time and on as many occasions as it deems appropriate, by any legally permitted means, including with a charge to profits and/or freely
distributable reserves, in accordance with applicable regulations. The maximum limit of treasury shares acquired by BBVA, either directly or through its subsidiaries, including those already held by BBVA and its subsidiaries at any given time, may
not exceed 10% of BBVA’s subscribed share capital, or any lower limit established by applicable legislation. The acquisition price per share may not be lower than its nominal value nor exceed by more than 10% the market price at the time of
purchase. The shares acquired may be allocated, in whole or in part, for delivery to employees or directors of BBVA or its subsidiaries, either directly or as a result of the exercise of option rights. Furthermore, BBVA’s board of directors has
been empowered to execute and implement this resolution in the broadest terms.

At the ordinary general shareholders’ meeting of BBVA
held on April 20, 2021, BBVA’s shareholders delegated to BBVA’s board of directors the authority to issue, on one or several occasions for a period of five years from the date on which this resolution was adopted, CoCos which are
intended to meet regulatory requirements for their eligibility as capital instruments, in accordance with the solvency regulations applicable from time to time, up to the maximum overall amount of €8